ID

15070

Descrizione

A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy Participants; ODM derived from: https://clinicaltrials.gov/show/NCT02343783

collegamento

https://clinicaltrials.gov/show/NCT02343783

Keywords

versioni (1)
  1. 14/05/16 14/05/16 -
Caricato su

14 maggio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Dermatitis, Atopic NCT02343783

Inglese

Eligibility Dermatitis, Atopic NCT02343783

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
participant must have signed an informed consent document prior to any study related procedures indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study
Descrizione

Informed Consent | Comprehension Study Protocol

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0162340
UMLS CUI [2,2]
C2348563
participant must be willing/able to adhere to the study visit schedule and other requirements, prohibitions and restrictions specified in this protocol
Descrizione

Compliance behavior Study Protocol

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C2348563
* for participants with asthma:
Descrizione

Study Subject | Asthma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0681850
UMLS CUI [2]
C0004096
participant must have a physician documented diagnosis of asthma for at least 12 months before screening
Descrizione

Asthma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004096
participant must have an asthma control questionnaire 6 (acq6) less than (<) 1.5 at screening
Descrizione

Asthma control questionnaire

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2919686
* for participants with atopic dermatitis:
Descrizione

Study Subject | Dermatitis, Atopic

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0681850
UMLS CUI [2]
C0011615
participant must have a physician documented diagnosis of atopic dermatitis for at least 12 months before screening based on uk refinement of the hanifin and rajka's diagnostic criteria
Descrizione

Dermatitis, Atopic

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011615
participant must have atopic dermatitis with and investigators global assessment (iga) score of 2 to 4 at screening
Descrizione

Dermatitis, Atopic | Assessment scale Clinical Investigators

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011615
UMLS CUI [2,1]
C0450973
UMLS CUI [2,2]
C0008961
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
participant has taken any prohibited or restricted medications as noted below under prestudy and concomitant therapy
Descrizione

Drugs, Non-Prescription | Pre-study Therapeutic procedure | Concomitant Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013231
UMLS CUI [2,1]
C1527048
UMLS CUI [2,2]
C0087111
UMLS CUI [3]
C1707479
participant has received an investigational drug (including investigational vaccines) or used an invasive investigational medical device within 6 weeks or 5 half-lives (whichever is longer) before the screening visit
Descrizione

Investigational New Drugs | INVESTIGATIONAL VACCINES | Investigational Medical Device

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230
UMLS CUI [2]
C1875384
UMLS CUI [3]
C2346570
* for participants with asthma:
Descrizione

Study Subject | Asthma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0681850
UMLS CUI [2]
C0004096
participant has a history of life-threatening asthma, defined as a history of respiratory arrest or requiring intubation for asthma
Descrizione

Asthma Life Threatening | Respiratory arrest | Requirement Intubation Asthma

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C2826244
UMLS CUI [2]
C0162297
UMLS CUI [3,1]
C1514873
UMLS CUI [3,2]
C0021925
UMLS CUI [3,3]
C0004096
participant had been admitted to a hospital for asthma in the 1 year before screening
Descrizione

Hospitalization Asthma

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C0004096
* for participants with atopic dermatitis:
Descrizione

Study Subject | Dermatitis, Atopic

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0681850
UMLS CUI [2]
C0011615
participant has evidence of any other skin condition that would interfere with assessment of atopic dermatitis (ad)
Descrizione

Other Skin condition Interferes with Evaluation Atopic Dermatitis

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C1719933
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C1261322
UMLS CUI [1,5]
C0011615
participant has active ad related infection or has had an active ad infection within 2 weeks of screening (participants with evidence of colonization on skin swab testing but with no infection are allowed)
Descrizione

Atopic Dermatitis Related Communicable Disease | Skin swab (lab test)

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0011615
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0009450
UMLS CUI [2]
C2266652
Ritorna all'inizio della pagina

Similar models

Eligibility Dermatitis, Atopic NCT02343783

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent | Comprehension Study Protocol
Item
participant must have signed an informed consent document prior to any study related procedures indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study
boolean
C0021430 (UMLS CUI [1])
C0162340 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
Compliance behavior Study Protocol
Item
participant must be willing/able to adhere to the study visit schedule and other requirements, prohibitions and restrictions specified in this protocol
boolean
C1321605 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Study Subject | Asthma
Item
* for participants with asthma:
boolean
C0681850 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
Asthma
Item
participant must have a physician documented diagnosis of asthma for at least 12 months before screening
boolean
C0004096 (UMLS CUI [1])
Asthma control questionnaire
Item
participant must have an asthma control questionnaire 6 (acq6) less than (<) 1.5 at screening
boolean
C2919686 (UMLS CUI [1])
Study Subject | Dermatitis, Atopic
Item
* for participants with atopic dermatitis:
boolean
C0681850 (UMLS CUI [1])
C0011615 (UMLS CUI [2])
Dermatitis, Atopic
Item
participant must have a physician documented diagnosis of atopic dermatitis for at least 12 months before screening based on uk refinement of the hanifin and rajka's diagnostic criteria
boolean
C0011615 (UMLS CUI [1])
Dermatitis, Atopic | Assessment scale Clinical Investigators
Item
participant must have atopic dermatitis with and investigators global assessment (iga) score of 2 to 4 at screening
boolean
C0011615 (UMLS CUI [1])
C0450973 (UMLS CUI [2,1])
C0008961 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Drugs, Non-Prescription | Pre-study Therapeutic procedure | Concomitant Therapy
Item
participant has taken any prohibited or restricted medications as noted below under prestudy and concomitant therapy
boolean
C0013231 (UMLS CUI [1])
C1527048 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C1707479 (UMLS CUI [3])
Investigational New Drugs | INVESTIGATIONAL VACCINES | Investigational Medical Device
Item
participant has received an investigational drug (including investigational vaccines) or used an invasive investigational medical device within 6 weeks or 5 half-lives (whichever is longer) before the screening visit
boolean
C0013230 (UMLS CUI [1])
C1875384 (UMLS CUI [2])
C2346570 (UMLS CUI [3])
Study Subject | Asthma
Item
* for participants with asthma:
boolean
C0681850 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
Asthma Life Threatening | Respiratory arrest | Requirement Intubation Asthma
Item
participant has a history of life-threatening asthma, defined as a history of respiratory arrest or requiring intubation for asthma
boolean
C0004096 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0162297 (UMLS CUI [2])
C1514873 (UMLS CUI [3,1])
C0021925 (UMLS CUI [3,2])
C0004096 (UMLS CUI [3,3])
Hospitalization Asthma
Item
participant had been admitted to a hospital for asthma in the 1 year before screening
boolean
C0019993 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
Study Subject | Dermatitis, Atopic
Item
* for participants with atopic dermatitis:
boolean
C0681850 (UMLS CUI [1])
C0011615 (UMLS CUI [2])
Other Skin condition Interferes with Evaluation Atopic Dermatitis
Item
participant has evidence of any other skin condition that would interfere with assessment of atopic dermatitis (ad)
boolean
C0205394 (UMLS CUI [1,1])
C1719933 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C1261322 (UMLS CUI [1,4])
C0011615 (UMLS CUI [1,5])
Atopic Dermatitis Related Communicable Disease | Skin swab (lab test)
Item
participant has active ad related infection or has had an active ad infection within 2 weeks of screening (participants with evidence of colonization on skin swab testing but with no infection are allowed)
boolean
C0011615 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0009450 (UMLS CUI [1,3])
C2266652 (UMLS CUI [2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial